Prior to the awareness of the expression of the fusion kinase in pediatric liver cancers, we had been working with the role of the HDAC1-Sp5 pathway in generated hbl and hcc/hcn-nos cell lines by inhibiting HDAC [38]. Here, SP5 is linked to liver cancer.